دورية أكاديمية
E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Continues: An Opportunity for Pharmacist Intervention.
| العنوان: | E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Continues: An Opportunity for Pharmacist Intervention. |
|---|---|
| المؤلفون: | Andrus MR; Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.; Department of Family Medicine, Huntsville Regional Medical Campus, The University of Alabama at Birmingham, Huntsville, AL, USA. |
| المصدر: | The Annals of pharmacotherapy [Ann Pharmacother] 2024 May; Vol. 58 (5), pp. 549-554. Date of Electronic Publication: 2023 Aug 21. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Sept. 2013- : Thousand Oaks, CA : Sage Original Publication: Cincinnati, OH : Harvey Whitney Books Co., c1992- |
| مواضيع طبية MeSH: | Electronic Nicotine Delivery Systems* , Lung Injury*/chemically induced , Lung Injury*/epidemiology , Vaping*/adverse effects, Humans ; Pandemics ; Pharmacists |
| مستخلص: | Electronic cigarette (e-cigarette), or vaping, product use-associated lung injury (EVALI) was first identified and reported in 2019, but media coverage and reporting of cases drastically decreased when the COVID-19 pandemic started in early 2020. The syndrome has continued to occur since that time and it is critical that pharmacists are aware of how EVALI presents, and when it should be considered as a potential diagnosis. Inpatient and outpatient pharmacists play a vital role in the treatment of EVALI, and should be knowledgeable of the utility of corticosteroids, even though data are extremely limited. Pharmacists should understand the importance of collecting detailed and accurate information about vaping from patient interviews. Pharmacists also play a leading role in cessation counseling and treatment, selecting medications that can be used to treat nicotine addiction from vaping, and assisting with transitions of care and follow-up. Competing Interests: Declaration of Conflicting InterestsThe author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
| فهرسة مساهمة: | Keywords: EVALI; electronic nicotine delivery systems; lung injury; pharmacists |
| تواريخ الأحداث: | Date Created: 20230822 Date Completed: 20240412 Latest Revision: 20240412 |
| رمز التحديث: | 20240412 |
| DOI: | 10.1177/10600280231193770 |
| PMID: | 37605427 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1542-6270 |
|---|---|
| DOI: | 10.1177/10600280231193770 |